American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 12(63), 2019
DOI: 10.1128/aac.01085-19
Full text: Unavailable
The pharmacokinetics (PK) and dialytic clearance of isavuconazole in vitro and in 7 solid-organ transplant patients undergoing continuous renal replacement therapy (CRRT) were evaluated.